Results
74,179 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Damani PriteshChief Technology Officer |  REAXReal REMAX Group Inc.Grant or award | A | — 58.2K sh | Sep 11, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Damani PriteshChief Technology Officer | REAXReal REMAX Group Inc. Grant or award | A | — 58.2K sh | Sep 11, 2026 |
| 9 | North John FDirector |  XPELXPEL, Inc.Option exercise | M | — 441 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 9 | Iyengar Vijay KDirector |  WHWKWhitehawk Therapeutics, Inc.Grant or award | A | — 76.1K sh | Sep 11, 2026 traded Sep 9, 2026 |
| 9 | Dolan John JosephChief Financial Officer |  EHTHeHealth, Inc.Tax withholding | F | $5,390 5,859 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 9 | Stueland KatherineDirector, CHIEF EXECUTIVE OFFICER |  WGSGeneDx Holdings Corp.Option exercise | M | — 6,547 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 9 | Singh Ritadhwaja JebensEVP & CHIEF DIGITAL OFFICER |  LTHLife Time Group Holdings, Inc.Option exercise | M | — 4,400 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 9 | Zahnd SaschaDirector |  LOGILOGITECH INTERNATIONAL S.A.Tax withholding | F | $13K 136 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 9 | Singh Ritadhwaja JebensEVP & CHIEF DIGITAL OFFICER | LTHLife Time Group Holdings, Inc. Option exercise | M | — 6,600 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 9 | Lumpkin AlexandraChief Legal Officer | REAXReal REMAX Group Inc. Grant or award | A | — 31.3K sh | Sep 11, 2026 traded Sep 9, 2026 |
| 9 | Villanueva Rodriguez AlfonsoEVP and Group CEO-VZ Consumer |  VZVERIZON COMMUNICATIONS INCGrant or award | A | $3,608 253 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 9 | Rozenblat JennaPresident | REAXReal REMAX Group Inc. Grant or award | A | — 58.1K sh | Sep 11, 2026 traded Sep 9, 2026 |
| 9 | Bugnion EdouardDirector | LOGILOGITECH INTERNATIONAL S.A. Tax withholding | F | $14K 138 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 9 | Ng Kwok WangDirector | LOGILOGITECH INTERNATIONAL S.A. Tax withholding | F | $13K 136 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 9 | Russo Joseph J.EVP&Pres-Global Networks&Tech | VZVERIZON COMMUNICATIONS INC Grant or award | A | $1,104 77 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 9 | Olsen Kevin M.Director, President and CEO |  DORMDorman Products, Inc.Option exercise | M | — 4,749 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 9 | Cain Wettan Keeley MEVP Gen Counsel, Legal & Comp |  GILDGILEAD SCIENCES, INC.Tax withholding | F | $41K 285 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 9 | Berger DietmarChief Medical Officer | GILDGILEAD SCIENCES, INC. Tax withholding | F | $38K 263 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 9 | O'Day Daniel PatrickDirector, Chairman & CEO | GILDGILEAD SCIENCES, INC. Option exercise | M | — 8,780 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 9 | Phillips GeoffreySr. VP, Operations |  GATXGATX CORPOption exercise | M | — 2,500 sh | Sep 11, 2026 traded Sep 11, 2026 |
| 9 | Cain Wettan Keeley MEVP Gen Counsel, Legal & Comp | GILDGILEAD SCIENCES, INC. Option exercise | M | — 590 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 9 | Singh Ritadhwaja JebensEVP & CHIEF DIGITAL OFFICER | LTHLife Time Group Holdings, Inc. Option exercise | M | — 7,729 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 9 | Boehme AlanDirector |  LOVELovesac CoOption exercise | M | — 5,238 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 9 | Meyer Seth HPresident |  HTGCHercules Capital, Inc.Tax withholding | F | $88.05 5 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 9 | Stillwell Mary-LeeSVP and Controller | VZVERIZON COMMUNICATIONS INC Grant or award | A | $585 41 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 9 | Parker Nicholas P.EVP, Worldwide Field Ops |  NVDANVIDIA CORPGrant or award | A | — 172.5K sh | Sep 11, 2026 traded Sep 9, 2026 |
| 9 | Berger DietmarChief Medical Officer | GILDGILEAD SCIENCES, INC. Option exercise | M | — 533 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 9 | Jani RaviChief Financial Officer | REAXReal REMAX Group Inc. Grant or award | A | — 27.5K sh | Sep 11, 2026 traded Sep 9, 2026 |
| 9 | Boehme AlanDirector | LOVELovesac Co Grant or award | A | — 5,238 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 9 | Mercier JohannaChief Comm & Corp Aff Officer | GILDGILEAD SCIENCES, INC. Option exercise | M | — 2,797 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 9 | Barbeau Michelle MarieChief Revenue Officer | EHTHeHealth, Inc. Tax withholding | F | $3,967 4,312 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 9 | Pandit SumitaChief Financial Officer |  GGenpact LTDGrant or award | A | — 76.7K sh | Sep 11, 2026 traded Sep 9, 2026 |
| 9 | Subramanian SanjayChief Financial Officer |  SCYXSCYNEXIS INCGrant or award | A | — 100.0K sh | Sep 11, 2026 traded Sep 9, 2026 |
| 9 | Venkatesh VandanaEVP and Chief Legal Officer | VZVERIZON COMMUNICATIONS INC Grant or award | A | $1,277 90 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 8 | Musunuri ShankarDirector, Chief Executive Officer |  OCGNOcugen, Inc.Open-market sale · 10b5-1 plan | SELL | $64K 57.3K sh | Sep 11, 2026 traded Sep 9, 2026 |
| 8 | Singh Ritadhwaja JebensEVP & CHIEF DIGITAL OFFICER | LTHLife Time Group Holdings, Inc. Option exercise | M | $128K 6,600 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 8 | Bawel David BenjaminSVP & CHIEF ACCOUNTING OFFICER |  DGICADONEGAL GROUP INCOption exercise | M | $120K 8,326 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 8 | Singh Ritadhwaja JebensEVP & CHIEF DIGITAL OFFICER | LTHLife Time Group Holdings, Inc. Option exercise | M | $76K 4,400 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 8 | Mercier JohannaChief Comm & Corp Aff Officer | GILDGILEAD SCIENCES, INC. Tax withholding | F | $195K 1,347 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 7 | Sibold William JohnDirector, President and CEO |  MDGLMADRIGAL PHARMACEUTICALS, INC.Open-market sale · 10b5-1 plan | SELL | $277K 522 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 7 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $273K 505 sh | Sep 11, 2026 traded Sep 9, 2026 |